<p>Concentrations of each of the bnAb that inhibited the target virus at 50–80% was pre-incubated with or without serial dilutions of 7 different monkey plasma samples (color coded) prior to adding virus. Deviations from this “no serum” control line indicates interference from the macaque sample with neutralization of the bnAb.</p
<p>After a 1 h pre-incubation of b12 minibodies or full-length b12 IgG (10 µg/ml) with HIV-1<sub>bal...
<p>(A) RhCMVIL-10-binding antibodies were analyzed throughout the immunization schedule (<a href="ht...
Background: It is widely appreciated that effective human vaccines directed against viral pathogens ...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV cont...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
<p>Data are an average of two macaques. Each pharmacokinetics study was repeated once or twice. (A) ...
Protection from immunodeficiency virus challenge in nonhuman primates (NHPs) by a first-generation H...
Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human c...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
It is widely appreciated that effective human vaccines directed against viral pathogens elicit neutr...
The role of vaccine-induced anti-V2 Abs was tested in three protection experiments in rhesus macaque...
Anti-HIV broadly neutralizing antibodies (bNAbs) may favor development of antiviral immunity by enga...
Some HIV-1-infected patients develop broad and potent HIV-1 neutralizing antibodies (bNAbs) that whe...
The antiviral properties of broadly neutralizing antibodies against HIV are well-documented but no v...
<p>After a 1 h pre-incubation of b12 minibodies or full-length b12 IgG (10 µg/ml) with HIV-1<sub>bal...
<p>(A) RhCMVIL-10-binding antibodies were analyzed throughout the immunization schedule (<a href="ht...
Background: It is widely appreciated that effective human vaccines directed against viral pathogens ...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV cont...
<p>(A) Plasma samples from the 11 macaques injected (color coded) were collected 2–3 weeks following...
<p>Data are an average of two macaques. Each pharmacokinetics study was repeated once or twice. (A) ...
Protection from immunodeficiency virus challenge in nonhuman primates (NHPs) by a first-generation H...
Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human c...
The identification of highly potent broadly neutralizing antibodies (bnAbs) against HIV-1, and succe...
It is widely appreciated that effective human vaccines directed against viral pathogens elicit neutr...
The role of vaccine-induced anti-V2 Abs was tested in three protection experiments in rhesus macaque...
Anti-HIV broadly neutralizing antibodies (bNAbs) may favor development of antiviral immunity by enga...
Some HIV-1-infected patients develop broad and potent HIV-1 neutralizing antibodies (bNAbs) that whe...
The antiviral properties of broadly neutralizing antibodies against HIV are well-documented but no v...
<p>After a 1 h pre-incubation of b12 minibodies or full-length b12 IgG (10 µg/ml) with HIV-1<sub>bal...
<p>(A) RhCMVIL-10-binding antibodies were analyzed throughout the immunization schedule (<a href="ht...
Background: It is widely appreciated that effective human vaccines directed against viral pathogens ...